首页> 外文会议>International Conference on Public Health and Data Science >From Evolution to Solution: Battling SARS-CoV-2
【24h】

From Evolution to Solution: Battling SARS-CoV-2

机译:从进化到解决方案:战斗SARS-COV-2

获取原文

摘要

SARS-CoV-2, the pathogen of an acute respiratory disease, COVID-19, has caused a new global public health crisis. SARS-CoV-2 has undergone several vital mutations which enhanced its ability of interpersonal transmission, and it is still evolving. Thus, a better understanding of the origin and evolution of the coronavirus will shed some light to controlling the disease. In addition to current therapies, the development of vaccines is becoming a promising solution. In this paper, epidemiological information about SARS-CoV-2 will be introduced, the evolution of the virus will be discussed and related to its enhanced infectiousness, and empirical studies focusing on relevant treatments and vaccines will be considered. It is proposed that developing nucleic acid vaccines is an approach more feasible. And basing the crosstalk of viral evolution and vaccine design, strategies relevant to experiences in treating SARS-CoV and MERS-CoV are also recommended.
机译:SARS-COV-2,Covid-19急性呼吸道疾病的病原体引起了新的全球公共卫生危机。 SARS-COV-2经过了几种重要突变,增强了其人际关系变速能力,并且仍在发展。因此,更好地了解冠状病毒的起源和演化将揭示一些光来控制疾病。除了当前的疗法外,疫苗的开发还在成为一个有前途的解决方案。本文将介绍关于SARS-COV-2的流行病学信息,将讨论病毒的演变,与其增强的传染病相关,并考虑对相关治疗和疫苗的实证研究。提出显影核酸疫苗是一种更可行的方法。还推荐了与病毒进化和疫苗设计的串扰,与治疗SARS-COV和MERS-COV相关的策略也是推荐的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号